However, these responses can be blunted (44), and glucagon secretion during insulin-induced hypoglycemia is usually impaired, if not completely absent, thereby raising the question as to whether the α cell is an accessible target to reduce hypoglycemic risk. The gene discussed is INS; the disease is Hypoglycemia.